Senda Biosciences Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Senda Biosciences, Inc. is a Cambridge, Massachusetts-based biotechnology research company focused on programmable medicines. It is developing SendRNA medicines through a proprietary platform that maps nature-derived programmable systems at the molecular level to enable programming of human cells, including intracellular mRNA, and to utilize natural delivery mechanisms. The platform includes an atlas of nature-derived programmable systems across life, enabling access to the full code provided by nature to program cells. Senda's SendRNA medicines are intended for infectious, genetic, autoimmune, and metabolic diseases and oncology indications, with potential implications for gene editing and protein-based therapies. Founded by Flagship Pioneering and headquartered in Cambridge, the company has a small team of 2-10 employees; recent activity in 2023 includes leadership appointments (Luke O'Neill as Chief Scientific Officer, Igor Matushansky as Chief Medical Officer, Marc Wolfgang as Senior Vice President of Manufacturing) and a partnership with Laronde.

Get verified Senda Biosciences emails free

Company overview Employee directory